These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 3932579
41. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. Chong AS, Scuderi P, Grimes WJ, Hersh EM. J Immunol; 1989 Mar 15; 142(6):2133-9. PubMed ID: 2493506 [Abstract] [Full Text] [Related]
42. Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukemia. Jiang YZ, Barrett AJ. Exp Hematol; 1995 Oct 15; 23(11):1167-72. PubMed ID: 7556526 [Abstract] [Full Text] [Related]
43. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity. Bonavida B, Wright SC. Adv Exp Med Biol; 1982 Oct 15; 146():379-88. PubMed ID: 7102465 [Abstract] [Full Text] [Related]
44. Characterization of natural killer cytotoxic factor (NKCF) from canine NK cells. Nakada Y, Soga M, Kosaka T, Tsukatani Y, Miyamori M, Kuwabara M, Tanaka S, Koide F, Fujiwara K. Vet Immunol Immunopathol; 1996 Jan 15; 49(4):283-93. PubMed ID: 8677631 [Abstract] [Full Text] [Related]
45. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells. Scott-Algara D, Vuillier F, Cayota A, Dighiero G. Clin Exp Immunol; 1992 Nov 15; 90(2):181-7. PubMed ID: 1424272 [Abstract] [Full Text] [Related]
46. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E. J Immunol; 1987 Sep 15; 139(6):1823-9. PubMed ID: 3114377 [Abstract] [Full Text] [Related]
47. Effects of X-ray irradiation on natural killer (NK) cell system. II. Increased sensitivity to natural killer cytotoxic factor (NKCF). Uchida A, Mizutani Y, Nagamuta M, Ikenaga M. Immunopharmacol Immunotoxicol; 1989 Sep 15; 11(2-3):521-34. PubMed ID: 2621326 [Abstract] [Full Text] [Related]
48. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. Burdach S, Shatsky M, Wagenhorst B, Levitt L. J Immunol; 1987 Jul 15; 139(2):452-8. PubMed ID: 3110272 [Abstract] [Full Text] [Related]
49. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis. Dickinson AM, Middleton SL, Latham J, Dunn J, Thomas L, Proctor SJ. Leukemia; 1995 Mar 15; 9(3):444-9. PubMed ID: 7533866 [Abstract] [Full Text] [Related]
50. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. Platzer E, Rubin BY, Lu L, Welte K, Broxmeyer HE, Moore MA. J Immunol; 1985 Jan 15; 134(1):265-71. PubMed ID: 3917276 [Abstract] [Full Text] [Related]
51. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. Celada A, Gray PW, Rinderknecht E, Schreiber RD. J Exp Med; 1984 Jul 01; 160(1):55-74. PubMed ID: 6330272 [Abstract] [Full Text] [Related]
52. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC, Hsiao MH, Pattengale PK. Nat Immun Cell Growth Regul; 1991 Jul 01; 10(2):57-70. PubMed ID: 1881400 [Abstract] [Full Text] [Related]
53. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG. Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943 [Abstract] [Full Text] [Related]
54. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity. Nakada Y, Tsukatani Y, Kosaka T, Kuwabara M, Tanaka S, Fujiwara K. Vet Immunol Immunopathol; 1997 Mar 01; 55(4):273-82. PubMed ID: 9151399 [Abstract] [Full Text] [Related]
55. Natural killer cell-mediated inhibition of bone marrow colony formation (CFU-GM) in refractory anaemia (preleukaemia): evidence for patient-specific cell populations. Kerndrup G, Hokland P. Br J Haematol; 1988 Aug 01; 69(4):457-62. PubMed ID: 3408683 [Abstract] [Full Text] [Related]
56. Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 molecule. Keever CA, Benazzi E, Kernan NA, Welte K, O'Reilly RJ, Bordignon C. Cell Immunol; 1988 Apr 15; 113(1):143-57. PubMed ID: 3259165 [Abstract] [Full Text] [Related]
57. Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells. Ayroldi E, Cannarile L, D'Adamio F, Delfino D, Migliorati G, Riccardi C. Nat Immun; 1992 Apr 15; 11(6):317-27. PubMed ID: 1477494 [Abstract] [Full Text] [Related]
58. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. Bonavida B, Katz J, Gottlieb M. J Immunol; 1986 Aug 15; 137(4):1157-63. PubMed ID: 3488345 [Abstract] [Full Text] [Related]
59. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay. Bradley TP, Bonavida B. Cell Immunol; 1984 Jan 15; 83(1):199-207. PubMed ID: 6420079 [Abstract] [Full Text] [Related]
60. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification. Roozemond RC, Mevissen M, Urli DC, Bonavida B. J Immunol; 1987 Sep 01; 139(5):1739-46. PubMed ID: 3624869 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]